Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 167, Issue 1, Pages 139-141Publisher
WILEY
DOI: 10.1111/bjh.12937
Keywords
chronic myeloid leukaemia; efficacy; generic; imatinib mesylate